Efficacy of vildagliptin on 10-year cardiovascular risk reduction in Thai patients with type 2 diabetes mellitus: A real-world observational study
Article in Diabetes & Metabolic Syndrome Clinical Research & Reviews (February 2022)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Vildagliptin Attenuates Myocardial Dysfunction and Restores Autophagy via miR-21/SPRY1/ERK in Diabetic Mice Heart
Article in Frontiers in Pharmacology (March 2021)
Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
Article in The Lancet (September 2019)